ConductScience.org, home

Gene · 6357

CCL13: C-C motif chemokine ligand 13

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. CCL13: C-C motif chemokine ligand 13. Genes, record 6357. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/6357

On this page

Gene

Symbol
CCL13
HGNC
Name
C-C motif chemokine ligand 13
HGNC
NCBI Gene ID
6357
NCBI Gene
HGNC ID
HGNC:10611
HGNC
Ensembl
ENSG00000181374
NCBI Gene
Aliases
CKb10, MCP-4, MGC17134, NCC-1, NCC1, SCYA13, SCYL1
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q99616C-C motif chemokine 13981Ensembl, GeneID, HGNC

Source UniProt

Patents124

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026120675 A2026-07-22729Q99616Espacenet
EP 4705273 A22026-03-11347Q99616Espacenet
JP 2026004568 A2026-01-1440995Q99616Espacenet
EP 4650780 A22025-11-19647Q99616Espacenet
JP 2025147176 A2025-10-062122Q99616Espacenet
JP 2025147176 A2025-10-0616623Q99616Espacenet
JP 2025529142 A2025-09-045745Q99616Espacenet
US 12371689 B22025-07-295745Q99616Espacenet
JP 2025517970 A2025-06-12647Q99616Espacenet
WO 2025081160 A12025-04-1747Q99616Espacenet

1 to 10 of 124

See all 124 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,928

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleCCL13 papersNewest fiscal year
P30CA016672Cancer Center Support Grant92025
UM1AI068613LC: HIV PREVENTION TRIALS NETWORK82025
P30CA008748Cancer Center Support Grant62025
P30ES010126UNC Center for Environmental Health and Susceptibility62025
UL1TR001866Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success62025
ZIAHD002400The Role Of Subclinical Infection And Cytokines In Preterm Parturition52025
P30AI094189The Johns Hopkins Center for AIDS Research (JHU CFAR)42025
P30AR075049Northwestern University Skin Biology and Diseases Resource-based Center42025
P30DK043351Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital42025
P51OD011092Support for National Primate Research Center42025

1 to 10 of 1,928Source NIH's project files

See all 1,928 nih grants

Papers3,018

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Advanced-stage cutaneous T-cell lymphomas show distinct immune profiles in erythroderma vs. tumor lesions.J Dermatol Sci202642810908PubTator, text miningPubMed
Fibroblast Heterogeneity Links Inflammatory Microenvironments to Tissue Remodeling in Chronic Rhinosinusitis.Int Arch Allergy Immunol202642809484PubTator, text miningPubMed
Molecular Heterogeneity in Clinically Ambiguous Atopic Dermatitis-Psoriasis Overlap: Compartment-Resolved Transcriptomic Profiling.Allergy202642788674PubTator, text miningPubMed
Correlation analysis of FABP3, MCP-4, and CXCL9 levels and myocardial damage in patients with severe pneumonia.J Med Biochem202642780731PubTator, text miningPubMed
Traditional Chinese medicine combined with conventional Western medicine for chronic cough following respiratory infection in children: a systematic review and meta-analysis.Transl Pediatr202642724356PubTator, text miningPubMed
Blood proteomics links systemic inflammation with early atherosclerosis in moderate-to-severe atopic dermatitis.J Invest Dermatol202642716219PubTator, text miningPubMed
Multimodal protective and susceptibility clusters in paediatric atopic dermatitis: A machine learning-based, data-driven observational study.PLoS Med202642709851PubTator, text miningPubMed
Inflammatory Serum Olink Proteomics in Cancer-Related Pain Treated with Opioids: A Pilot Cross-Sectional and Longitudinal Study.J Proteome Res202642695881PubTator, text miningPubMed
Tear Cytokine Signature in Vernal Keratoconjunctivitis: A Chemokine-Remodeling Axis Associated with Disease Severity.Int J Mol Sci202642653185PubTator, text miningPubMed
Clinical Improvement and Immune Signatures Following Platelet-Rich Plasma Therapy for Post-Viral Olfactory Dysfunction.Int Forum Allergy Rhinol202642599689PubTator, text miningPubMed

1 to 10 of 3,018

See all 3,018 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/6357

GET https://conductscience.org/api/genes/v1/6357/patents?page=2